ArchivesMagazine - 30 Jul 2015Synairgen on takeover list Trial results and market potential may trigger a bid for asthma therapy developer 30 July 2015|Small Caps Issue: 30 Jul 2015 - Page 30 < Feast On Dividends Empresaria surges ahead > Issue: 30 Jul 2015 - Page 30 | Contents Next: Empresaria surges ahead Previous: Feast On Dividends Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Mark Dunne Issue Contents Chartist FTSE 100 opportunities Databank The Best & Worst Performers: FTSE 350, Global Market, Commodities, Forex, Sovereign Yields Diary Preview: Standard Chartered Director Deals Director dealings: Top buys & Sells Stiff eyes happy ending Feature Corporate cannibals Feast On Dividends Forex Canadian dollar woes Funds Neptune’s alpha quest Griller Wake up to Vast Resources Letters What we are saying Mr Market Investing in Students News News in brief: RSA, Randgold, Staffline, Bwin.Party, Quarto, Tungsten, Gaming Realms First-half earnings strong Dialight in the dark Alzheimer’s healthcare push Green light for Vodafone Pearson fails to excite Bets are on at Ladbrokes ‘Carnage’ in high yield Morgan’s material growth Step back from Merlin Entering the Pantheon Opinion Commodities chaos Personal Finance Money Matters: ISAs vs SIPPS Plays 15 for 2015 update: Safestay Plays update: GKN Go bananas for Fyffes Plays update: Ashtead Plays update: Arbuthnot Banking Inland Homes stands tall Sector Reports Fintech’s big prospects Small Caps Empresaria surges ahead Synairgen on takeover list Ideagen eyes record breakers Symphony is out of tune Talking Point Beeb bashing: Stock winners